Neuronetics, Inc.
STIM
$4.41
-$0.22-4.75%
| Weiss Ratings | STIM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | STIM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | STIM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.03 | |||
| Price History | STIM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -12.85% | |||
| 30-Day Total Return | 37.81% | |||
| 60-Day Total Return | 280.17% | |||
| 90-Day Total Return | 312.15% | |||
| Year to Date Total Return | 195.97% | |||
| 1-Year Total Return | 4.50% | |||
| 2-Year Total Return | 51.03% | |||
| 3-Year Total Return | 46.03% | |||
| 5-Year Total Return | 112.02% | |||
| 52-Week High % Change | -21.79% | |||
| 52-Week Low % Change | 790.38% | |||
| Price | STIM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $5.92 | |||
| 52-Week Low Price | $0.52 | |||
| 52-Week Low Price (Date) | Nov 12, 2024 | |||
| 52-Week High Price (Date) | Mar 05, 2025 | |||
| Valuation | STIM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 257.80M | |||
| Enterprise Value | 317.87M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.22 | |||
| Earnings Per Share Growth | 3.71% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.93 | |||
| Price/Book (Q) | 14.96 | |||
| Enterprise Value/Revenue (TTM) | 4.37 | |||
| Price | $4.41 | |||
| Enterprise Value/EBITDA (TTM) | -13.54 | |||
| Enterprise Value/EBIT | -12.46 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | STIM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 30.27M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | STIM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 610 640 4202 | |||
| Address | 3222 Phoenixville Pike Malvern, PA 19355 | |||
| Website | neurostar.com | |||
| Country | United States | |||
| Year Founded | 2001 | |||
| Profitability | STIM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -35.09% | |||
| Profit Margin | -50.09% | |||
| Management Effectiveness | STIM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -19.09% | |||
| Return on Equity | -- | |||
| Income Statement | STIM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 72.71M | |||
| Total Revenue (TTM) | 72.71M | |||
| Revenue Per Share | $2.40 | |||
| Gross Profit (TTM) | 56.94M | |||
| EBITDA (TTM) | -23.48M | |||
| EBIT (TTM) | -25.52M | |||
| Net Income (TTM) | -36.42M | |||
| Net Income Avl. to Common (TTM) | -36.42M | |||
| Total Revenue Growth (Q YOY) | 3.61% | |||
| Earnings Growth (Q YOY) | -42.06% | |||
| EPS Diluted (TTM) | -1.22 | |||
| EPS Diluted Growth (Q YOY) | -35.55% | |||
| Balance Sheet | STIM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 20.87M | |||
| Cash Per Share (Q) | $0.69 | |||
| Total Current Assets (Q) | 53.46M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 9.38M | |||
| Current Ratio (Q) | 3.164 | |||
| Book Value Per Share (Q) | $0.31 | |||
| Total Assets (Q) | 74.12M | |||
| Total Current Liabilities (Q) | 16.90M | |||
| Total Debt (Q) | 48.70M | |||
| Total Liabilities (Q) | 64.74M | |||
| Total Common Equity (Q) | 9.38M | |||
| Cash Flow | STIM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -600.00K | |||
| Cash from Financing (TTM) | 5.89M | |||
| Net Change in Cash (TTM) | -14.98M | |||
| Levered Free Cash Flow (TTM) | -11.50M | |||
| Cash from Operations (TTM) | -20.27M | |||
